Receptor Activator of Nuclear Factor Kappa B (RANK) Expression in Primary Breast Cancer Correlates with Recurrence Free Survival and Development of Bone Metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657)

PURPOSE: The Receptor Activator of Nuclear Factor Kappa B (RANK)/RANK ligand (RANKL)/Osteoprotegerin (OPG) axis may contribute to the development of bone metastases (BM). We studied gene expression in this pathway in primary breast cancer (BC) to determine correlations with clinical characteristics...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Vidula, Neelima, Yau, Christina, Li, Jiali, Esserman, Laura J., Rugo, Hope S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725604/
https://ncbi.nlm.nih.gov/pubmed/28577080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4318-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados